Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Mini-Review Article

Is It Time to Consider the Androgen Receptor as a Therapeutic Target in Breast Cancer?

Author(s): Melika Kooshki Forooshani, Rosa Scarpitta, Giuseppe Nicolò Fanelli, Mario Miccoli, Antonio Giuseppe Naccarato and Cristian Scatena*

Volume 22, Issue 4, 2022

Published on: 18 January, 2022

Page: [775 - 786] Pages: 12

DOI: 10.2174/1871520621666211201150818

Price: $65

Abstract

Breast Cancer (BC) is a heterogeneous disease and the most prevalent malignant tumor in women worldwide. The majority of BC cases are positive for Estrogen Receptor (ER) and Progesterone Receptor (PgR), both known to be involved in cancer pathogenesis, progression, and invasion. In line with this, hormonal deprivation therapy appears to be a useful tool and an effective treatment for these BC subtypes. Unfortunately, prognosis among patients with hormone-negative tumors or therapy-refractory and metastatic patients remains poor. Novel biomarkers are urgently needed in order to predict the course of the disease, make better therapy decisions and improve the overall survival of patients. In this respect, the Androgen Receptor (AR), a member of the hormonal nuclear receptor superfamily and ER and PgR, emerges as an interesting feature widely expressed in human BCs. Despite the advances, the precise tumorigenic mechanism of AR and the role of its endogenous ligands are yet not well-understood. In this review, we aim to elaborate on the prognostic impact of AR expression and current AR-targeting approaches based on previous studies investigating AR's role in different BC subtypes.

Keywords: Breast Cancer (BC), Androgen Receptor (AR), clinical trial, Disease-Free Survival (DFS), molecular targeted therapy, Immunohistochemistry (IHC), Triple-Negative Breast Cancer (TNBC).

Graphical Abstract

[1]
Carioli, G.; Malvezzi, M.; Rodriguez, T.; Bertuccio, P.; Negri, E.; La Vecchia, C. Trends and predictions to 2020 in breast cancer mortality in Europe. Breast, 2017, 36, 89-95.
[http://dx.doi.org/10.1016/j.breast.2017.06.003] [PMID: 28988610]
[2]
Wu, X.; Gardashova, G.; Lan, L.; Han, S.; Zhong, C.; Marquez, R.T.; Wei, L.; Wood, S.; Roy, S.; Gowthaman, R.; Karanicolas, J.; Gao, F.P.; Dixon, D.A.; Welch, D.R.; Li, L.; Ji, M.; Aubé, J.; Xu, L. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis. Commun. Biol., 2020, 3(1), 193.
[http://dx.doi.org/10.1038/s42003-020-0933-1] [PMID: 32332873]
[3]
Provenzano, E.; Ulaner, G.A.; Chin, S-F. Molecular classification of breast cancer. PET Clin., 2018, 13(3), 325-338.
[http://dx.doi.org/10.1016/j.cpet.2018.02.004] [PMID: 30100073]
[4]
Makki, J. Diversity of breast carcinoma: histological subtypes and clinical relevance. Clin. Med. Insights Pathol., 2015, 8 CPath.S31563.
[http://dx.doi.org/10.4137/CPath.S31563]
[5]
Tan, P.H.; Ellis, I.; Allison, K.; Brogi, E.; Fox, S.B.; Lakhani, S.; Lazar, A.J.; Morris, E.A.; Sahin, A.; Salgado, R.; Sapino, A.; Sasano, H.; Schnitt, S.; Sotiriou, C.; van Diest, P.; White, V.A.; Lokuhetty, D.; Cree, I.A. The 2019 World health organization classification of tumours of the breast. Histopathology, 2020, 77(2), 181-185.
[http://dx.doi.org/10.1111/his.14091] [PMID: 32056259]
[6]
Russnes, H.G.; Lingjærde, O.C.; Børresen-Dale, A-L.; Caldas, C. Breast cancer molecular stratification: from intrinsic subtypes to integrative Clusters. Am. J. Pathol., 2017, 187(10), 2152-2162.
[http://dx.doi.org/10.1016/j.ajpath.2017.04.022] [PMID: 28733194]
[7]
Dias, K.; Dvorkin-Gheva, A.; Hallett, R.M.; Wu, Y.; Hassell, J.; Pond, G.R.; Levine, M.; Whelan, T.; Bane, A.L. Claudin-low breast cancer; clinical & pathological characteristics. PLoS One, 2017, 12(1),e0168669.
[http://dx.doi.org/10.1371/journal.pone.0168669] [PMID: 28045912]
[8]
Cocco, S.; Piezzo, M.; Calabrese, A.; Cianniello, D.; Caputo, R.; Lauro, V.D.; Fusco, G.; Gioia, G.D.; Licenziato, M.; De Laurentiis, M. Biomarkers in triple-negative breast cancer: state-of-the-art and future perspectives. Int. J. Mol. Sci., 2020, 21(13), 4579.
[http://dx.doi.org/10.3390/ijms21134579] [PMID: 32605126]
[9]
Louie, M.C.; Sevigny, M.B. Steroid hormone receptors as prognostic markers in breast cancer. Am. J. Cancer Res., 2017, 7(8), 1617-1636.
[PMID: 28861319]
[10]
Vasiliou, S.K.; Diamandis, E.P. Androgen receptor: a promising therapeutic target in breast cancer. Crit. Rev. Clin. Lab. Sci., 2019, 56(3), 200-223.
[http://dx.doi.org/10.1080/10408363.2019.1575643] [PMID: 30821186]
[11]
Mohanty, S.S.; Sahoo, C.R.; Padhy, R.N. Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: an update. Genes Dis., 2020.
[http://dx.doi.org/10.1016/j.gendis.2020.12.005]
[12]
Caparica, R.; Lambertini, M.; de Azambuja, E.; How, I. How I treat metastatic triple-negative breast cancer. ESMO Open, 2019, 4(Suppl. 2),e000504.
[http://dx.doi.org/10.1136/esmoopen-2019-000504] [PMID: 31231572]
[13]
Wellenstein, M.D.; de Visser, K.E. Cancer-cell-intrinsic mechanisms shaping the tumor immune landscape. Immunity, 2018, 48(3), 399-416.
[http://dx.doi.org/10.1016/j.immuni.2018.03.004] [PMID: 29562192]
[14]
Brandão, M.; Maurer, C.; Ziegelmann, P.K.; Pondé, N.F.; Ferreira, A.; Martel, S.; Piccart, M.; de Azambuja, E.; Debiasi, M.; Lambertini, M. Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis. ESMO Open, 2020, 5(4),e000842.
[http://dx.doi.org/10.1136/esmoopen-2020-000842] [PMID: 32847835]
[15]
Daemen, A.; Manning, G. HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors. Breast Cancer Res., 2018, 20(1), 8.
[http://dx.doi.org/10.1186/s13058-018-0933-y] [PMID: 29382369]
[16]
Chen, Z.; Lan, X.; Wu, D.; Sunkel, B.; Ye, Z.; Huang, J.; Liu, Z.; Clinton, S.K.; Jin, V.X.; Wang, Q. Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer. Nat. Commun., 2015, 6(1), 8323.
[http://dx.doi.org/10.1038/ncomms9323] [PMID: 26374485]
[17]
Rampurwala, M.; Wisinski, K.B.; O’Regan, R. Role of the androgen receptor in triple-negative. Clin. Adv. Hematol. Oncol., 2016, 14(3), 186-193.
[PMID: 27058032]
[18]
Narayanan, R.; Coss, C.C.; Dalton, J.T. Development of Selective Androgen Receptor Modulators (SARMs). Mol. Cell. Endocrinol., 2018, 465, 134-142.
[http://dx.doi.org/10.1016/j.mce.2017.06.013] [PMID: 28624515]
[19]
Jameera Begam, A.; Jubie, S.; Nanjan, M.J. Estrogen receptor agonists/antagonists in breast cancer therapy: a critical review. Bioorg. Chem., 2017, 71, 257-274.
[http://dx.doi.org/10.1016/j.bioorg.2017.02.011] [PMID: 28274582]
[20]
Mehta, J.; Asthana, S.; Mandal, C.C.; Saxena, S. A molecular analysis provides novel insights into androgen receptor signalling in breast cancer. PLoS One, 2015, 10(3),e0120622.
[http://dx.doi.org/10.1371/journal.pone.0120622] [PMID: 25781993]
[21]
Basile, D.; Cinausero, M.; Iacono, D.; Pelizzari, G.; Bonotto, M.; Vitale, M.G.; Gerratana, L.; Puglisi, F. Androgen receptor in estrogen receptor positive breast cancer: beyond expression. Cancer Treat. Rev., 2017, 61, 15-22.
[http://dx.doi.org/10.1016/j.ctrv.2017.09.006] [PMID: 29078133]
[22]
Davey, R.A.; Grossmann, M. Androgen receptor structure, function and biology: from bench to bedside. Clin. Biochem. Rev., 2016, 37(1), 3-15.
[PMID: 27057074]
[23]
Iggo, R.D. New insights into the role of androgen and oestrogen receptors in molecular apocrine breast tumours. Breast Cancer Res., 2011, 13(6), 318.
[http://dx.doi.org/10.1186/bcr3036] [PMID: 22188611]
[24]
Giovannelli, P.; Di Donato, M.; Galasso, G.; Di Zazzo, E.; Bilancio, A.; Migliaccio, A. The androgen receptor in breast cancer. Front. Endocrinol. (Lausanne), 2018, 9, 492.
[http://dx.doi.org/10.3389/fendo.2018.00492] [PMID: 30210453]
[25]
Wasmuth, E.V.; Hoover, E.A.; Antar, A.; Klinge, S.; Chen, Y.; Sawyers, C.L. Modulation of androgen receptor DNA binding activity through direct interaction with the ETS transcription factor ERG. Proc. Natl. Acad. Sci. USA, 2020, 117(15), 8584-8592.
[http://dx.doi.org/10.1073/pnas.1922159117] [PMID: 32220959]
[26]
Karamouzis, M.V.; Papavassiliou, K.A.; Adamopoulos, C.; Papavassiliou, A.G. Targeting androgen/estrogen receptors crosstalk in cancer. Trends Cancer, 2016, 2(1), 35-48.
[http://dx.doi.org/10.1016/j.trecan.2015.12.001] [PMID: 28741499]
[27]
Rahim, B.; O’Regan, R. AR signaling in breast cancer. Cancers (Basel), 2017, 9(3), 21.
[http://dx.doi.org/10.3390/cancers9030021] [PMID: 28245550]
[28]
Feng, J.; Li, L.; Zhang, N.; Liu, J.; Zhang, L.; Gao, H.; Wang, G.; Li, Y.; Zhang, Y.; Li, X.; Liu, D.; Lu, J.; Huang, B. Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms. Oncogene, 2017, 36(20), 2775-2790.
[http://dx.doi.org/10.1038/onc.2016.432] [PMID: 27893717]
[29]
Secreto, G.; Venturelli, E.; Meneghini, E.; Carcangiu, M.L.; Paolini, B.; Agresti, R.; Pellitteri, C.; Berrino, F.; Gion, M.; Cogliati, P.; Saragò, G.; Micheli, A. Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers. BMC Cancer, 2012, 12(1), 599.
[http://dx.doi.org/10.1186/1471-2407-12-599] [PMID: 23241075]
[30]
Weigel, N.L.; Zhang, Y. Ligand-independent activation of steroid hormone receptors. J. Mol. Med. (Berl.), 1998, 76(7), 469-479.
[http://dx.doi.org/10.1007/s001090050241] [PMID: 9660165]
[31]
Kensler, K.H.; Regan, M.M.; Heng, Y.J.; Baker, G.M.; Pyle, M.E.; Schnitt, S.J.; Hazra, A.; Kammler, R.; Thürlimann, B.; Colleoni, M.; Viale, G.; Brown, M.; Tamimi, R.M. Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the breast international group trial 1-98. Breast Cancer Res., 2019, 21(1), 30.
[http://dx.doi.org/10.1186/s13058-019-1118-z] [PMID: 30795773]
[32]
García, X.; Elía, A.; Galizzi, L.; May, M.; Spengler, E.; Martínez Vázquez, P.; Burruchaga, J.; Gass, H.; Lanari, C.; Lamb, C.A. Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer. Breast Cancer Res. Treat., 2020, 180(1), 257-263.
[http://dx.doi.org/10.1007/s10549-020-05527-3] [PMID: 31950383]
[33]
Elebro, K.; Bendahl, P-O.; Jernström, H.; Borgquist, S. Androgen receptor expression and breast cancer mortality in a population-based prospective cohort. Breast Cancer Res. Treat., 2017, 165(3), 645-657.
[http://dx.doi.org/10.1007/s10549-017-4343-0] [PMID: 28643022]
[34]
Kensler, K.H.; Poole, E.M.; Heng, Y.J.; Collins, L.C.; Glass, B.; Beck, A.H.; Hazra, A.; Rosner, B.A.; Eliassen, A.H.; Hankinson, S.E.; Winer, E.P.; Brown, M.; Tamimi, R.M. Androgen receptor expression and breast cancer survival: results from the nurses’ health studies. J. Natl. Cancer Inst., 2019, 111(7), 700-708.
[http://dx.doi.org/10.1093/jnci/djy173] [PMID: 30445651]
[35]
Hwang, K-T.; Kim, Y.A.; Kim, J.; Park, J.H.; Choi, I.S.; Hwang, K.R.; Chai, Y.J.; Park, J.H. Influence of androgen receptor on the prognosis of breast cancer. J. Clin. Med., 2020, 9(4), 1083.
[http://dx.doi.org/10.3390/jcm9041083] [PMID: 32290220]
[36]
Niméus, E.; Folkesson, E.; Nodin, B.; Hartman, L.; Klintman, M. Androgen receptor in stage I-II primary breast cancer -prognostic value and distribution in subgroups. Anticancer Res., 2017, 37(12), 6845-6853.
[http://dx.doi.org/10.21873/anticanres.12146] [PMID: 29187464]
[37]
Elebro, K.; Borgquist, S.; Simonsson, M.; Markkula, A.; Jirström, K.; Ingvar, C.; Rose, C.; Jernström, H. Combined androgen and estrogen receptor status in breast cancer: treatment prediction and prognosis in a population-based prospective cohort. Clin. Cancer Res., 2015, 21(16), 3640-3650.
[http://dx.doi.org/10.1158/1078-0432.CCR-14-2564] [PMID: 25904752]
[38]
Agrawal, A.; Ziolkowski, P.; Grzebieniak, Z.; Jelen, M.; Bobinski, P.; Agrawal, S. Expression of androgen receptor in estrogen receptor-positive breast cancer. Appl. Immunohistochem. Mol. Morphol., 2016, 24(8), 550-555.
[http://dx.doi.org/10.1097/PAI.0000000000000234] [PMID: 26230371]
[39]
Yang, Y.; Min, A.; Lee, K-H.; Ryu, H.S.; Kim, T-Y.; Woo, G.U.; Suh, K.J.; Lee, D-W.; Lee, H-B.; Moon, H-G.; Han, W.; Park, I.A.; Noh, D-Y. Im, S.A. Prognostic role of androgen receptor expression in surgically resected early breast cancer patients. J. Breast Cancer, 2020, 23(2), 182-193.
[http://dx.doi.org/10.4048/jbc.2020.23.e28] [PMID: 32395377]
[40]
Kraby, M.R.; Valla, M.; Opdahl, S.; Haugen, O.A.; Sawicka, J.E.; Engstrøm, M.J.; Bofin, A.M. The prognostic value of androgen receptors in breast cancer subtypes. Breast Cancer Res. Treat., 2018, 172(2), 283-296.
[http://dx.doi.org/10.1007/s10549-018-4904-x] [PMID: 30109519]
[41]
Micello, D.; Marando, A.; Sahnane, N.; Riva, C.; Capella, C.; Sessa, F. Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers. Virchows Arch., 2010, 457(4), 467-476.
[http://dx.doi.org/10.1007/s00428-010-0964-y] [PMID: 20809337]
[42]
Agoff, S.N.; Swanson, P.E.; Linden, H.; Hawes, S.E.; Lawton, T.J. Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations. Am. J. Clin. Pathol., 2003, 120(5), 725-731.
[http://dx.doi.org/10.1309/42F00D0DJD0J5EDT] [PMID: 14608899]
[43]
Kucukzeybek, B.B.; Bayoglu, I.V.; Kucukzeybek, Y.; Yıldız, Y.; Oflazoglu, U.; Atahan, M.K.; Taskaynatan, H.; Alacacioglu, A.; Yigit, S.; Tarhan, M.O. Prognostic significance of androgen receptor expression in HER2-positive and triple-negative breast cancer. Pol. J. Pathol., 2018, 69(2), 157-168.
[http://dx.doi.org/10.5114/pjp.2018.76699] [PMID: 30351863]
[44]
Dieci, M.V.; Tsvetkova, V.; Griguolo, G.; Miglietta, F.; Mantiero, M.; Tasca, G.; Cumerlato, E.; Giorgi, C.A.; Giarratano, T.; Faggioni, G.; Falci, C.; Vernaci, G.; Menichetti, A.; Mioranza, E.; Di Liso, E.; Frezzini, S.; Saibene, T.; Orvieto, E.; Guarneri, V. Androgen receptor expression and association with distant disease-free survival in triple negative breast cancer: analysis of 263 patients treated with standard therapy for stage I-III Disease. Front. Oncol., 2019, 9, 452.
[http://dx.doi.org/10.3389/fonc.2019.00452] [PMID: 31245286]
[45]
Hu, X-Q.; Chen, W-L.; Ma, H-G.; Jiang, K. Androgen receptor expression identifies patient with favorable outcome in operable triple negative breast cancer. Oncotarget, 2017, 8, 56364-56374.
[http://dx.doi.org/10.18632/oncotarget.16913] [PMID: 28915596]
[46]
Sunar, V.; Dogan, H.T.; Sarici, F.; Ates, O.; Akin, S.; Baspinar, B.; Aksoy, S.; Altundag, K. Association between androgen receptor status and prognosis in triple negative breast cancer. J. BUON, 2018, 23(5), 1325-1330.
[PMID: 30570854]
[47]
Astvatsaturyan, K.; Yue, Y.; Walts, A.E.; Bose, S. Androgen receptor positive triple negative breast cancer: clinicopathologic, prognostic, and predictive features. PLoS One, 2018, 13(6),e0197827.
[http://dx.doi.org/10.1371/journal.pone.0197827] [PMID: 29883487]
[48]
Park, C.H.; Kim, E.Y.; Do, S.-I. Clinicopathologic significance of androgen receptor expression and discordant receptor status during progression in breast cancer. Ann. Oncol.,, 2018, 29((Suppl. 8)), VIII64.
[http://dx.doi.org/10.1093/annonc/mdy270.195]
[49]
Asano, Y.; Kashiwagi, S.; Goto, W.; Tanaka, S.; Morisaki, T.; Takashima, T.; Noda, S.; Onoda, N.; Ohsawa, M.; Hirakawa, K.; Ohira, M. Expression and clinical significance of androgen receptor in triple-negative breast cancer. Cancers (Basel), 2017, 9(1), 4.
[http://dx.doi.org/10.3390/cancers9010004] [PMID: 28067809]
[50]
Lyalkin, S.A.; Verevkina, N.O.; Alekseyenko, O.O.; Syvak, L.A. Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer. Exp. Oncol., 2020, 42(2), 140-143.
[http://dx.doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14579] [PMID: 32602289]
[51]
Bhattarai, S.; Klimov, S.; Mittal, K.; Krishnamurti, U.; Li, X.B.; Oprea-Ilies, G.; Wetherilt, C.S.; Riaz, A.; Aleskandarany, M.A.; Green, A.R.; Ellis, I.O.; Cantuaria, G.; Gupta, M.; Manne, U.; Agboola, J.; Baskovich, B.; Janssen, E.A.M.; Callagy, G.; Walsh, E.M.; Mehta, A.; Dogra, A.; Shet, T.; Gajaria, P.; Traina, T.; Nggada, H.A.; Omonisi, A.; Ahmed, S.A.; Rakha, E.A.; Rida, P.; Aneja, R. Prognostic role of androgen receptor in triple negative breast cancer: a multi-institutional study. Cancers (Basel), 2019, 11(7), 995.
[http://dx.doi.org/10.3390/cancers11070995] [PMID: 31319547]
[52]
Shen, H.; Yang, Y.; Zhao, L.; Yuan, J.; Niu, Y. Lin28A and androgen receptor expression in ER-/Her2+ breast cancer. Breast Cancer Res. Treat., 2016, 156(1), 135-147.
[http://dx.doi.org/10.1007/s10549-016-3744-9] [PMID: 26944953]
[53]
Wang, X.; Bi, X.; Huang, Z.; Huang, J.; Xia, W.; Shi, W.; Yuan, Z. The prognostic value of androgen receptor (AR) in HER2-enriched metastatic breast cancer. Endocr. Relat. Cancer, 2020, 27(4), 199-208.
[http://dx.doi.org/10.1530/ERC-19-0315] [PMID: 31958314]
[54]
van Rooijen, J.M.; Qiu, S-Q.; Timmer-Bosscha, H.; van der Vegt, B.; Boers, J.E.; Schröder, C.P.; de Vries, E.G.E. Androgen receptor expression inversely correlates with immune cell infiltration in human epidermal growth factor receptor 2-positive breast cancer. Eur. J. Cancer, 2018, 103, 52-60.
[http://dx.doi.org/10.1016/j.ejca.2018.08.001] [PMID: 30208359]
[55]
Akashi, M.; Yamaguchi, R.; Kusano, H.; Ogasawara, S.; Abe, E.; Obara, H.; Yamaguchi, M.; Akiba, J.; Kakuma, T.; Tanaka, M.; Akagi, Y.; Yano, H. Androgen receptor expression is useful to predict the therapeutic effect in HER2-positive breast carcinoma. Breast Cancer Res. Treat., 2020, 184(2), 277-285.
[http://dx.doi.org/10.1007/s10549-020-05855-4] [PMID: 32770457]
[56]
Arslan, C.; Isik, M.; Guler, G.; Kulac, I.; Solak, M.; Turker, B.; Ozisik, Y.; Altundag, K. Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer? Am. Surg., 2012, 78(9), 992-999.
[http://dx.doi.org/10.1177/000313481207800941] [PMID: 22964210]
[57]
He, L.; Du, Z.; Xiong, X.; Ma, H.; Zhu, Z.; Gao, H.; Cao, J.; Li, T.; Li, H.; Yang, K.; Chen, G.; Richer, J.K.; Gu, H. Targeting androgen receptor in treating HER2 positive breast cancer. Sci. Rep., 2017, 7(1), 14584.
[http://dx.doi.org/10.1038/s41598-017-14607-2] [PMID: 29109513]
[58]
Kollara, A.; Kahn, H.J.; Marks, A.; Brown, T.J. Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers. Breast Cancer Res. Treat., 2001, 67(3), 245-253.
[http://dx.doi.org/10.1023/A:1017938608460] [PMID: 11561770]
[59]
Bronte, G.; Rocca, A.; Ravaioli, S.; Puccetti, M.; Tumedei, M.M.; Scarpi, E.; Andreis, D.; Maltoni, R.; Sarti, S.; Cecconetto, L.; Fedeli, A.; Pietri, E.; De Simone, V.; Asioli, S.; Amadori, D.; Bravaccini, S. Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy? BMC Cancer, 2018, 18(1), 348.
[http://dx.doi.org/10.1186/s12885-018-4239-3] [PMID: 29587674]
[60]
Grogg, A.; Trippel, M.; Pfaltz, K.; Lädrach, C.; Droeser, R.A.; Cihoric, N.; Salhia, B.; Zweifel, M.; Tapia, C. Androgen receptor status is highly conserved during tumor progression of breast cancer. BMC Cancer, 2015, 15(1), 872.
[http://dx.doi.org/10.1186/s12885-015-1897-2] [PMID: 26552477]
[61]
Kim, J-Y.; Park, K.; Lee, E.; Jung, H.H.; Ahn, J.S. Im, Y.H.; Park, W.Y.; Park, Y.H. The effect of androgen receptor expression on clinical characterization of metastatic breast cancer. Oncotarget, 2017, 8(5), 8693-8706.
[http://dx.doi.org/10.18632/oncotarget.14414] [PMID: 28060723]
[62]
Aceto, N.; Bardia, A.; Wittner, B.S.; Donaldson, M.C.; O’Keefe, R.; Engstrom, A.; Bersani, F.; Zheng, Y.; Comaills, V.; Niederhoffer, K.; Zhu, H.; Mackenzie, O.; Shioda, T.; Sgroi, D.; Kapur, R.; Ting, D.T.; Moy, B.; Ramaswamy, S.; Toner, M.; Haber, D.A.; Maheswaran, S. AR Expression in breast cancer CTCs associates with bone metastases. Mol. Cancer Res., 2018, 16(4), 720-727.
[http://dx.doi.org/10.1158/1541-7786.MCR-17-0480] [PMID: 29453314]
[63]
de Kruijff, I.E.; Sieuwerts, A.M.; Onstenk, W.; Jager, A.; Hamberg, P.; de Jongh, F.E.; Smid, M.; Kraan, J.; Timmermans, M.A.; Martens, J.W.M.; Sleijfer, S. Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer. Int. J. Cancer, 2019, 145(4), 1083-1089.
[http://dx.doi.org/10.1002/ijc.32209] [PMID: 30761532]
[64]
Schippinger, W.; Regitnig, P.; Dandachi, N.; Wernecke, K-D.; Bauernhofer, T.; Samonigg, H.; Moinfar, F. Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer. Virchows Arch., 2006, 449(1), 24-30.
[http://dx.doi.org/10.1007/s00428-006-0213-6] [PMID: 16628414]
[65]
Humphries, M.P.; Sundara Rajan, S.; Honarpisheh, H.; Cserni, G.; Dent, J.; Fulford, L.; Jordan, L.B.; Jones, J.L.; Kanthan, R.; Litwiniuk, M.; Di Benedetto, A.; Mottolese, M.; Provenzano, E.; Shousha, S.; Stephens, M.; Kulka, J.; Ellis, I.O.; Titloye, A.N.; Hanby, A.M.; Shaaban, A.M.; Speirs, V. Characterisation of male breast cancer: a descriptive biomarker study from a large patient series. Sci. Rep., 2017, 7(1), 45293.
[http://dx.doi.org/10.1038/srep45293] [PMID: 28350011]
[66]
Di Lauro, L.; Vici, P.; Barba, M.; Pizzuti, L.; Sergi, D.; Rinaldi, M.; Di Benedetto, A.; Sperduti, I.; Shaaban, A.M.; Speirs, V.; Mottolese, M.; De Maria, R.; Maugeri-Saccà, M. Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series. Breast Cancer Res. Treat., 2014, 148(1), 73-80.
[http://dx.doi.org/10.1007/s10549-014-3138-9] [PMID: 25238881]
[67]
Scatena, C.; Scarpitta, R.; Innocenti, L.; Miccoli, M.; Biancotti, R.; Diodati, L.; Ghilli, M.; Naccarato, A.G. Androgen receptor expression inversely correlates with histological grade and N stage in ER+/PgRlow male breast cancer. Breast Cancer Res. Treat., 2020, 182(1), 55-65.
[http://dx.doi.org/10.1007/s10549-020-05682-7] [PMID: 32436149]
[68]
Rangel, N.; Rondon-Lagos, M.; Annaratone, L.; Aristizábal-Pachon, A.F.; Cassoni, P.; Sapino, A.; Castellano, I. AR/ER ratio correlates with expression of proliferation markers and with distinct subset of breast tumors. Cells, 2020, 9(4), 1064.
[http://dx.doi.org/10.3390/cells9041064] [PMID: 32344660]
[69]
Rangel, N.; Rondon-Lagos, M.; Annaratone, L.; Osella-Abate, S.; Metovic, J.; Mano, M.P.; Bertero, L.; Cassoni, P.; Sapino, A.; Castellano, I. The role of the AR/ER ratio in ER-positive breast cancer patients. Endocr. Relat. Cancer, 2018, 25(3), 163-172.
[http://dx.doi.org/10.1530/ERC-17-0417] [PMID: 29386247]
[70]
Bronte, G.; Rocca, A.; Ravaioli, S.; Scarpi, E.; Bonafè, M.; Puccetti, M.; Maltoni, R.; Andreis, D.; Martinelli, G.; Bravaccini, S. Evaluation of androgen receptor in relation to estrogen receptor (AR/ER) and progesterone receptor (AR/PgR): a new must in breast cancer? J. Oncol., 2019, 2019,1393505.
[http://dx.doi.org/10.1155/2019/1393505] [PMID: 31110518]
[71]
Perrault, D.J.; Logan, D.M.; Stewart, D.J.; Bramwell, V.H.C.; Paterson, A.H.G.; Eisenhauer, E.A. Phase II study of flutamide in patients with metastatic breast cancer. A national cancer institute of Canada clinical trials group study. Invest. New Drugs, 1988, 6(3), 207-210.
[http://dx.doi.org/10.1007/BF00175399] [PMID: 3192386]
[72]
Zhao, T.P.; He, G.F. A phase II clinical trial of flutamide in the treatment of advanced breast cancer. Tumori, 1988, 74(1), 53-56.
[http://dx.doi.org/10.1177/030089168807400109] [PMID: 3354065]
[73]
Gucalp, A.; Tolaney, S.; Isakoff, S.J.; Ingle, J.N.; Liu, M.C.; Carey, L.A.; Blackwell, K.; Rugo, H.; Nabell, L.; Forero, A.; Stearns, V.; Doane, A.S.; Danso, M.; Moynahan, M.E.; Momen, L.F.; Gonzalez, J.M.; Akhtar, A.; Giri, D.D.; Patil, S.; Feigin, K.N.; Hudis, C.A.; Traina, T.A. Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer. Clin. Cancer Res., 2013, 19(19), 5505-5512.
[http://dx.doi.org/10.1158/1078-0432.CCR-12-3327] [PMID: 23965901]
[74]
Bonnefoi, H.; Grellety, T.; Tredan, O.; Saghatchian, M.; Dalenc, F.; Mailliez, A.; L’Haridon, T.; Cottu, P.; Abadie-Lacourtoisie, S.; You, B.; Mousseau, M.; Dauba, J.; Del Piano, F.; Desmoulins, I.; Coussy, F.; Madranges, N.; Grenier, J.; Bidard, F.C.; Proudhon, C.; MacGrogan, G.; Orsini, C.; Pulido, M.; Gonçalves, A. A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1). Ann. Oncol., 2016, 27(5), 812-818.
[http://dx.doi.org/10.1093/annonc/mdw067] [PMID: 27052658]
[75]
O’Shaughnessy, J.; Campone, M.; Brain, E.; Neven, P.; Hayes, D.; Bondarenko, I.; Griffin, T.W.; Martin, J.; De Porre, P.; Kheoh, T.; Yu, M.K.; Peng, W.; Johnston, S. Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer. Ann. Oncol., 2016, 27(1), 106-113.
[http://dx.doi.org/10.1093/annonc/mdv487] [PMID: 26504153]
[76]
Lu, Q.; Xia, W.; Lee, K.; Zhang, J.; Yuan, H.; Yuan, Z.; Shi, Y.; Wang, S.; Xu, F. Bicalutamide plus aromatase inhibitor in patients with estrogen receptor-positive/androgen receptor-positive advanced breast cancer. Oncologist, 2020, 25(1), 21-e15.
[http://dx.doi.org/10.1634/theoncologist.2019-0564] [PMID: 31434793]
[77]
Bardia, A.; Gucalp, A.; DaCosta, N.; Gabrail, N.; Danso, M.; Ali, H.; Blackwell, K.L.; Carey, L.A.; Eisner, J.R.; Baskin-Bey, E.S.; Traina, T.A. Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer. Breast Cancer Res. Treat., 2018, 171(1), 111-120.
[http://dx.doi.org/10.1007/s10549-018-4813-z] [PMID: 29744674]
[78]
Traina, T.A.; Miller, K.; Yardley, D.A.; Eakle, J.; Schwartzberg, L.S.; O’Shaughnessy, J.; Gradishar, W.; Schmid, P.; Winer, E.; Kelly, C.; Nanda, R.; Gucalp, A.; Awada, A.; Garcia-Estevez, L.; Trudeau, M.E.; Steinberg, J.; Uppal, H.; Tudor, I.C.; Peterson, A.; Cortes, J. Enzalutamide for the treatment of androgen receptor-expressing triple-negative breast cancer. J. Clin. Oncol., 2018, 36(9), 884-890.
[http://dx.doi.org/10.1200/JCO.2016.71.3495] [PMID: 29373071]
[79]
Ndubaku, C.O.; Heffron, T.P.; Staben, S.T.; Baumgardner, M.; Blaquiere, N.; Bradley, E.; Bull, R.; Do, S.; Dotson, J.; Dudley, D.; Edgar, K.A.; Friedman, L.S.; Goldsmith, R.; Heald, R.A.; Kolesnikov, A.; Lee, L.; Lewis, C.; Nannini, M.; Nonomiya, J.; Pang, J.; Price, S.; Prior, W.W.; Salphati, L.; Sideris, S.; Wallin, J.J.; Wang, L.; Wei, B.; Sampath, D.; Olivero, A.G. Discovery of 2-{3-[2-(1-isopropyl-3-methyl-1 H -1,2–4-triazol-5-Yl)-5,6-dihydrobenzo[f]imidazo[1,2- d ][1,4]oxazepin-9-Yl]-1 H -pyrazol-1-Yl}-2-methylpropanamide (GDC-0032): a β-sparing phosphoinositide 3-kinase inhibitor with high unbound exposure and robust in vivo antitumor activity. J. Med. Chem., 2013, 56(11), 4597-4610.
[http://dx.doi.org/10.1021/jm4003632] [PMID: 23662903]
[80]
Lehmann, B.D.; Abramson, V.G.; Sanders, M.E.; Mayer, E.L.; Haddad, T.C.; Nanda, R.; Van Poznak, C.; Storniolo, A.M.; Nangia, J.R.; Gonzalez-Ericsson, P.I.; Sanchez, V.; Johnson, K.N.; Abramson, R.G.; Chen, S-C.; Shyr, Y.; Arteaga, C.L.; Wolff, A.C.; Pietenpol, J.A. TBCRC 032 IB/II multicenter study: molecular insights to AR antagonist and PI3K inhibitor efficacy in patients with AR+ metastatic triple-negative breast cancer. Clin. Cancer Res., 2020, 26(9), 2111-2123.
[http://dx.doi.org/10.1158/1078-0432.CCR-19-2170] [PMID: 31822498]
[81]
Kono, M.; Fujii, T.; Lyons, G.R.; Huo, L.; Bassett, R.; Gong, Y.; Karuturi, M.S.; Tripathy, D.; Ueno, N.T. Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy. Breast Cancer Res. Treat., 2016, 160(1), 101-109.
[http://dx.doi.org/10.1007/s10549-016-3986-6] [PMID: 27663436]
[82]
Pietri, E.; Massa, I.; Bravaccini, S.; Ravaioli, S.; Tumedei, M.M.; Petracci, E.; Donati, C.; Schirone, A.; Piacentini, F.; Gianni, L.; Nicolini, M.; Campadelli, E.; Gennari, A.; Saba, A.; Campi, B.; Valmorri, L.; Andreis, D.; Fabbri, F.; Amadori, D.; Rocca, A. Phase II study of dehydroepiandrosterone in androgen receptor-positive metastatic breast cancer. Oncologist, 2019, 24(6), 743-e205.
[http://dx.doi.org/10.1634/theoncologist.2018-0243] [PMID: 30591548]
[83]
Rampurwala, M.; Wisinski, K.B.; Burkard, M.E.; Ehsani, S.; O’Regan, R.M.; Carmichael, L.; Kim, K.; Kolesar, J.; Tevaarwerk, A.J. Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer. Invest. New Drugs, 2017, 35(1), 87-94.
[http://dx.doi.org/10.1007/s10637-016-0403-2] [PMID: 27826831]
[84]
Schwartzberg, L.S.; Yardley, D.A.; Elias, A.D.; Patel, M.; LoRusso, P.; Burris, H.A.; Gucalp, A.; Peterson, A.C.; Blaney, M.E.; Steinberg, J.L.; Gibbons, J.A.; Traina, T.A. A Phase I/Ib study of enzalutamide alone and in combination with endocrine therapies in women with advanced breast cancer. Clin. Cancer Res., 2017, 23(15), 4046-4054.
[http://dx.doi.org/10.1158/1078-0432.CCR-16-2339] [PMID: 28280092]
[85]
Zweifel, M.; Thürlimann, B.; Riniker, S.; Weder, P.; von Moos, R.; Pagani, O.; Bigler, M.; Rothgiesser, K.M.; Pilop, C.; Hawle, H.; Brauchli, P.; Tapia, C.; Schoenfeld, W.; Sessa, C. Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients. Endocr. Connect., 2017, 6(7), 549-556.
[http://dx.doi.org/10.1530/EC-17-0174] [PMID: 28814476]
[86]
Park, S.; Koo, J.; Park, H.S.; Kim, J-H.; Choi, S-Y.; Lee, J.H.; Park, B-W.; Lee, K.S. Expression of androgen receptors in primary breast cancer. Ann. Oncol., 2010, 21(3), 488-492.
[http://dx.doi.org/10.1093/annonc/mdp510] [PMID: 19887463]
[87]
Christenson, J.L.; Trepel, J.B.; Ali, H.Y.; Lee, S.; Eisner, J.R.; Baskin-Bey, E.S.; Elias, A.D.; Richer, J.K. Harnessing a different dependency: how to identify and target androgen receptor-positive versus quadruple-negative breast cancer. Horm. Cancer, 2018, 9(2), 82-94.
[http://dx.doi.org/10.1007/s12672-017-0314-5] [PMID: 29340907]
[88]
Hickey, T.E.; Irvine, C.M.; Dvinge, H.; Tarulli, G.A.; Hanson, A.R.; Ryan, N.K.; Pickering, M.A.; Birrell, S.N.; Hu, D.G.; Mackenzie, P.I.; Russell, R.; Caldas, C.; Raj, G.V.; Dehm, S.M.; Plymate, S.R.; Bradley, R.K.; Tilley, W.D.; Selth, L.A. Expression of androgen receptor splice variants in clinical breast cancers. Oncotarget, 2015, 6(42), 44728-44744.
[http://dx.doi.org/10.18632/oncotarget.6296] [PMID: 26554309]
[89]
Hu, D.G.; Hickey, T.E.; Irvine, C.; Wijayakumara, D.D.; Lu, L.; Tilley, W.D.; Selth, L.A.; Mackenzie, P.I. Identification of androgen receptor splice variant transcripts in breast cancer cell lines and human tissues. Horm. Cancer, 2014, 5(2), 61-71.
[http://dx.doi.org/10.1007/s12672-014-0171-4] [PMID: 24570075]
[90]
Bronte, G.; Bravaccini, S.; Ravaioli, S.; Puccetti, M.; Scarpi, E.; Andreis, D.; Tumedei, M.M.; Sarti, S.; Cecconetto, L.; Pietri, E.; De Simone, V.; Maltoni, R.; Bonafè, M.; Amadori, D.; Rocca, A. Androgen receptor expression in breast cancer: what differences between primary tumor and metastases? Transl. Oncol., 2018, 11(4), 950-956.
[http://dx.doi.org/10.1016/j.tranon.2018.05.006] [PMID: 29890379]
[91]
Meng, X.; Song, S.; Jiang, Z-F.; Sun, B.; Wang, T.; Zhang, S.; Wu, S. Receptor conversion in metastatic breast cancer: a prognosticator of survival. Oncotarget, 2016, 7(44), 71887-71903.
[http://dx.doi.org/10.18632/oncotarget.12114] [PMID: 27655689]
[92]
Varela, C.L.; Amaral, C.; Tavares da Silva, E.; Lopes, A.; Correia-da-Silva, G.; Carvalho, R.A.; Costa, S.C.P.; Roleira, F.M.F.; Teixeira, N. Exemestane metabolites: synthesis, stereochemical elucidation, biochemical activity and anti-proliferative effects in a hormone-dependent breast cancer cell line. Eur. J. Med. Chem., 2014, 87, 336-345.
[http://dx.doi.org/10.1016/j.ejmech.2014.09.074] [PMID: 25277066]
[93]
Amaral, C.; Lopes, A.; Varela, C.L.; da Silva, E.T.; Roleira, F.M.F.; Correia-da-Silva, G.; Teixeira, N. Exemestane metabolites suppress growth of estrogen receptor-positive breast cancer cells by inducing apoptosis and autophagy: a comparative study with exemestane. Int. J. Biochem. Cell Biol., 2015, 69, 183-195.
[http://dx.doi.org/10.1016/j.biocel.2015.10.024] [PMID: 26515125]
[94]
Goss, P.E.; Ingle, J.N.; Pritchard, K.I.; Robert, N.J.; Muss, H.; Gralow, J.; Gelmon, K.; Whelan, T.; Strasser-Weippl, K.; Rubin, S.; Sturtz, K.; Wolff, A.C.; Winer, E.; Hudis, C.; Stopeck, A.; Beck, J.T.; Kaur, J.S.; Whelan, K.; Tu, D.; Parulekar, W.R. Extending Aromatase-inhibitor adjuvant therapy to 10 Years. N. Engl. J. Med., 2016, 375(3), 209-219.
[http://dx.doi.org/10.1056/NEJMoa1604700] [PMID: 27264120]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy
Request history8.2.27PHP Version293msRequest Duration28MBMemory UsageGET article/{article_id}/{param?}Route
  • warninglog[21:16:32] LOG.warning: Optional parameter $article_id declared before required parameter $request i...
  • warninglog[21:16:32] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • warninglog[21:16:32] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[21:16:32] LOG.warning: strip_tags(): Passing null to parameter #1 ($string) of type string is depre...
  • warninglog[21:16:32] LOG.warning: strip_tags(): Passing null to parameter #1 ($string) of type string is depre...
  • warninglog[21:16:32] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • Booting (93.25ms)time
  • Application (200ms)time
  • 1 x Application (68.19%)
    200ms
    1 x Booting (31.81%)
    93.25ms
    14 templates were rendered
    • articlearticle.blade.php#?blade
    • includes.article_top_bannerarticle_top_banner.blade.php#?blade
    • includes.article_referencearticle_reference.blade.php#?blade
    • export_citation_formexport_citation_form.blade.php#?blade
    • includes.article_bottom_bannerarticle_bottom_banner.blade.php#?blade
    • includes.inc_related_journalsinc_related_journals.blade.php#?blade
    • includes.inc_related_ebooksinc_related_ebooks.blade.php#?blade
    • includes.journal_rightmenujournal_rightmenu.blade.php#?blade
    • includes.journal_right_bannerjournal_right_banner.blade.php#?blade
    • layouts.appapp.blade.php#?blade
    • layouts._login_access_login_access.blade.php#?blade
    • layouts._header_header.blade.php#?blade
    • layouts._main_menu_main_menu.blade.php#?blade
    • layouts._footer_menu_footer_menu.blade.php#?blade
    uri
    GET article/{article_id}/{param?}
    middleware
    web, check_user_access
    controller
    App\Http\Controllers\ArticleController@GetArticleDetails
    namespace
    App\Http\Controllers
    where
    as
    article
    file
    app/Http/Controllers/ArticleController.php:1974-2510
    36 statements were executed, 4 of which were duplicates, 32 unique. Show only duplicated104ms
    • Connection Establishedalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 9. middleware::check_user_access:24
      • 10. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 11. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address (ip_address,visitor_agent,visitor_count, created_on,updated_on) VALUES ('316674267','',1,1740345392,1740345392) ON DUPLICATE KEY UPDATE visitor_count=visitor_count + 1, updated_on=1740345392
      1.05msalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 11. middleware::check_user_access:24
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address_detail (ip_address,visitor_url,visitor_count, created_on,updated_on) VALUES ('316674267','/article/119179',1,1740345392,1740345392)
      160μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#27
      Backtrace
      • 11. middleware::check_user_access:27
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_trail WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_corporate WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_token WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_trail WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_corporate WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_token WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_trail WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_corporate WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_token WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_trail WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_corporate WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_token WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_trail WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_corporate WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_token WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_disease_corporate WHERE to_ip >= 316674267 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316674267) limit 1
      14.37msalphaeurekaselec_live_10_06_2022UserAccess.php#784
      Bindings
      • 0: 316674267
      • 1: 316674267
      • 2: 316674267
      • 3: 316674267
      • 4: 316674267
      • 5: 316674267
      • 6: 316674267
      • 7: 316674267
      • 8: 316674267
      • 9: 316674267
      • 10: 316674267
      • 11: 316674267
      • 12: 316674267
      • 13: 316674267
      • 14: 316674267
      • 15: 316674267
      Backtrace
      • 14. app/Models/UserAccess/UserAccess.php:784
      • 15. middleware::check_user_access:114
      • 16. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 18. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
    • SELECT at.type_name, p.copyright, p.publisher_location,m.month,y.year, a.publish_on, a.nid article_nid,a.article_id, a.pmid, a.issue_id, a.title, a.abstract,a.podcast,a.altmetric_score,a.altmetric_url,a.kudos_url, a.page_count, a.first_page, a.elocator, a.last_page, i.publication_date, a.file_name, a.file_path, a.doi, a.is_epub,a.epub_type, a.volume_id, a.is_uploaded, a.editor_choice, a.is_epub, j.image_file_name, a.article_no, a.art_type AS article_type, a.supplementary_filename,a.html_filename,a.prc_filename,a.epub_filename, a.graph_abs_lg_filename, a.graph_abs_sm_filename, a.oa_image_lg_filename, a.oa_image_sm_filename, j.journal_banner,a.animated_abstract,a.erratum_in,a.erratum_for, (CASE WHEN a.issue_id =0 THEN j.epub_price ELSE j.price END) AS sell_price, j.epub_price, j.nid AS jour_nid, j.title AS journal_title, j.issn, j.eissn,j.journal_id, j.subtitle AS jour_subtitle, v.volume_id,v.volume_name AS volume, v.year_id, i.title AS issue, i.month_id ,i.type issue_type, j.subtitle,j.formerly_title, ac.subtitle AS epub_title,a.crossmark_enabled,a.text_mining_urls,a.license_urls,a.created, a.receivedate, a.revisedate, a.acceptdate,js.js_title FROM article a LEFT JOIN article_section ac ON a.is_epub = ac.art_sec_id LEFT JOIN journal_section js ON a.js_id = js.js_id LEFT JOIN article_type at ON a.art_type = at.art_type_id LEFT JOIN issue i ON a.issue_id = i.issue_id LEFT JOIN month m ON m.id = i.month_id LEFT JOIN volume v ON v.volume_id = a.volume_id INNER JOIN year y ON y.id = v.year_id INNER JOIN journal j ON j.journal_id = a.journal_id INNER JOIN publisher p ON p.publisher_id = j.publisher_id WHERE a.article_id=119179
      770μsalphaeurekaselec_live_10_06_2022Article.php#408
      Backtrace
      • 11. app/Models/Article.php:408
      • 12. app/Http/Controllers/ArticleController.php:2515
      • 13. app/Http/Controllers/ArticleController.php:2035
      • 14. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 15. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `journal` where `journal_id` = 1 limit 1
      840μsalphaeurekaselec_live_10_06_2022Journal.php#64
      Bindings
      • 0: 1
      Backtrace
      • 14. app/Models/Journal.php:64
      • 15. app/Http/Controllers/ArticleController.php:2516
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=1) and sj.journal_id!=1 group by `j`.`nid`) as `aggregate_table`
      1.21msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 16. app/Models/Subject.php:200
      • 17. app/Http/Controllers/ArticleController.php:2517
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=1) and sj.journal_id!=1 group by `j`.`nid` order by `j`.`journal_id` asc limit 10 offset 0
      1.02msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 14. app/Models/Subject.php:200
      • 15. app/Http/Controllers/ArticleController.php:2517
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=1) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid`) as `aggregate_table`
      3.19msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 16. app/Models/Subject.php:220
      • 17. app/Http/Controllers/ArticleController.php:2518
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=1) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid` order by `v`.`ebook_volume_id` desc limit 10 offset 0
      2.7msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 14. app/Models/Subject.php:220
      • 15. app/Http/Controllers/ArticleController.php:2518
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `keywords` where `article_id` = '119179'
      2.01msalphaeurekaselec_live_10_06_2022Keywords.php#43
      Bindings
      • 0: 119179
      Backtrace
      • 13. app/Models/Keywords.php:43
      • 14. app/Http/Controllers/ArticleController.php:2519
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `article_citation` where `article_id` = '119179'
      4.01msalphaeurekaselec_live_10_06_2022Article.php#1570
      Bindings
      • 0: 119179
      Backtrace
      • 13. app/Models/Article.php:1570
      • 14. app/Http/Controllers/ArticleController.php:2520
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select CONCAT_WS(' ',au.first_name, ' ', ifnull(au.initials,''), ' ', au.last_name) as authors, CONCAT(au.last_name, IFNULL(CONCAT(' ', au.initials), ''), ' ', au.first_name) AS authorsRIS, CONCAT_WS(' ',au.last_name, ' ', ifnull(au.initials,''), ' ', au.first_name) as authorsCiteAs, CONCAT_WS(' ',au.first_name, IFNULL(CONCAT(' ', au.initials), ''), IFNULL(CONCAT(' ', au.last_name), '')) as authorsmodal , `au`.*, `af`.`ror_id`, `af`.`institution`, `af`.`department`, `af`.`country`, `af`.`city`, `af`.`address`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.institution,','),''), ifnull(concat(af.department,','),''), ifnull(concat(af.address,','),''), ifnull(concat(af.city,','),''), ifnull(concat(af.country,','),''), ifnull(concat(af.postal_code,','),''), ifnull(concat(af.phone,','),''), ifnull(concat(af.fax,','),''))) SEPARATOR '|')) as `author_affiliation`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.web_view,','),''))) SEPARATOR '|')) as `web_view` from `author` as `au` left join `author_affiliation` as `af` on `au`.`author_id` = `af`.`author_id` where `au`.`article_id` = '119179' group by `au`.`author_id` order by `au`.`article_id` asc, `au`.`sequence` asc
      2.39msalphaeurekaselec_live_10_06_2022Author.php#86
      Bindings
      • 0: 119179
      Backtrace
      • 13. app/Models/Author.php:86
      • 14. app/Http/Controllers/ArticleController.php:2533
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      260μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2535
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `subtitle` from `journal` where `continues_publication_journal` = 1
      480μsalphaeurekaselec_live_10_06_2022Article.php#1960
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/Article.php:1960
      • 14. app/Http/Controllers/ArticleController.php:2062
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • Select j.subtitle, v.volume_id as volume_id,v.year_id,y.year as year,v.volume_name, v.total_no_of_issues, i.issue_id as issue_id,i.title as issue, i.publication_date as issue_pub_date from journal j join volume v on j.journal_id = v.journal_id join issue i on v.volume_id = i.volume_id join article a on a.issue_id = i.issue_id join year y on v.year_id = y.id where j.journal_id = 1 and i.is_uploaded = 1 order by v.volume_name+0 desc, i.title+0 desc limit 1
      26.98msalphaeurekaselec_live_10_06_2022Issue.php#298
      Backtrace
      • 11. app/Models/Issue.php:298
      • 12. app/Http/Controllers/ArticleController.php:2068
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 1 and a.journal_id = 1 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      14.84msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2070
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 4 and a.journal_id = 1 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      11.04msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2071
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select pdf, html, epub, prc from `article_metrics` where `article_id` = 119179 limit 1
      320μsalphaeurekaselec_live_10_06_2022Article.php#744
      Bindings
      • 0: 119179
      Backtrace
      • 14. app/Models/Article.php:744
      • 15. app/Http/Controllers/ArticleController.php:2091
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from content_by_diseases where content_id = 119179 and content_type = 'article' order by status desc limit 1
      330μsalphaeurekaselec_live_10_06_2022Article.php#751
      Backtrace
      • 11. app/Models/Article.php:751
      • 12. app/Http/Controllers/ArticleController.php:2094
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `node_meta` where `nid` = 198469 limit 1
      690μsalphaeurekaselec_live_10_06_2022Meta.php#30
      Bindings
      • 0: 198469
      Backtrace
      • 14. app/Models/Meta.php:30
      • 15. app/Http/Controllers/ArticleController.php:2101
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      260μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2108
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `tbl_ht_submission` as `h` where `h`.`subtitle` = 'ACAMC' and (h.proposal_closing_date = 0 OR TO_DAYS(FROM_UNIXTIME(h.proposal_closing_date)) >= TO_DAYS(NOW())) order by `h`.`manuscript` asc
      330μsalphaeurekaselec_live_10_06_2022Article.php#2025
      Bindings
      • 0: ACAMC
      Backtrace
      • 13. app/Models/Article.php:2025
      • 14. app/Http/Controllers/ArticleController.php:2112
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '119179' and content_type = 'a' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      450μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2186
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '11296' and content_type = 'i' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      330μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2207
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '3166' and content_type = 'v' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      290μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2231
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 316674267 and j.to_ip >=316674267 )) and ((j.from_date <= 1740345392 and j.to_date >= 1740345392 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 3166) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 316674267 and j.to_ip >=316674267 )) and ((j.from_date <= 1740345392 and j.to_date >= 1740345392 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 3166) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 316674267 and j.to_ip >=316674267 )) and ((j.from_date <= 1740345392 and j.to_date >= 1740345392 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 3166)
      6.43msalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2272
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 316674267 and j.to_ip >=316674267 )) and ((j.from_date <= 1740345392 and j.to_date >= 1740345392 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 11296) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 316674267 and j.to_ip >=316674267 )) and ((j.from_date <= 1740345392 and j.to_date >= 1740345392 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 11296) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 316674267 and j.to_ip >=316674267 )) and ((j.from_date <= 1740345392 and j.to_date >= 1740345392 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 11296)
      660μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2297
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 316674267 and j.to_ip >=316674267 )) and ((j.from_date <= 1740345392 and j.to_date >= 1740345392 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 119179) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 316674267 and j.to_ip >=316674267 )) and ((j.from_date <= 1740345392 and j.to_date >= 1740345392 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 119179) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 316674267 and j.to_ip >=316674267 )) and ((j.from_date <= 1740345392 and j.to_date >= 1740345392 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 119179)
      590μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2329
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `first_page` < '775' and is_uploaded = 1 and issue_id = 11296 order by cast(first_page as SIGNED) desc limit 1
      580μsalphaeurekaselec_live_10_06_2022Article.php#1819
      Bindings
      • 0: 775
      Backtrace
      • 14. app/Models/Article.php:1819
      • 15. app/Http/Controllers/ArticleController.php:2470
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `last_page` > '786' and is_uploaded = 1 and issue_id = 11296 order by cast(first_page as SIGNED) asc limit 1
      500μsalphaeurekaselec_live_10_06_2022Article.php#1831
      Bindings
      • 0: 786
      Backtrace
      • 14. app/Models/Article.php:1831
      • 15. app/Http/Controllers/ArticleController.php:2472
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `language_id` from `multilanguage` where `short_code` = 'en'
      190μsalphaeurekaselec_live_10_06_2022ArticleController.php#2497
      Bindings
      • 0: en
      Backtrace
      • 14. app/Http/Controllers/ArticleController.php:2497
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `source_lang_label`, `target_lang_label` from `multilanguage_labels` where `target_lang_id` = 1
      190μsalphaeurekaselec_live_10_06_2022MultiLanguage.php#23
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/MultiLanguage.php:23
      • 14. app/Http/Controllers/ArticleController.php:2498
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `id` from `multilanguage_article` where `article_id` = 119179 limit 1
      2.33msalphaeurekaselec_live_10_06_2022ArticleController.php#2506
      Bindings
      • 0: 119179
      Backtrace
      • 16. app/Http/Controllers/ArticleController.php:2506
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 20. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 1 and `b`.`banner_from_date` <= 1740345392 and `b`.`banner_to_date` >= 1740345392 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.13msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 1
      • 3: 1740345392
      • 4: 1740345392
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 1 and `b`.`banner_from_date` <= 1740345392 and `b`.`banner_to_date` >= 1740345392 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.04msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 1
      • 3: 1740345392
      • 4: 1740345392
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select count(*) as aggregate from `uc_cart_products` where cart_id='abb4c2f41c78be3cf7bf186319db5bc7'
      190μsalphaeurekaselec_live_10_06_2022Cart.php#271
      Backtrace
      • 15. app/Models/Cart.php:271
      • 16. view::layouts._header:260
      • 18. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 20. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    App\Models\MultiLanguage
    1MultiLanguage.php#?
        _token
        vsjGpG4ceaVU6o2Ug9Rb7qHBhVc7ir5Xmkf7P6Su
        uc_cart_id
        abb4c2f41c78be3cf7bf186319db5bc7
        _previous
        array:1 [ "url" => "https://alpha.eurekaselect.com/article/119179" ]
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /article/119179
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:17 [ "x-https" => array:1 [ 0 => "1" ] "host" => array:1 [ 0 => "alpha.eurekaselect.com" ] "priority" => array:1 [ 0 => "u=0, i" ] "cookie" => array:1 [ 0 => "wayfindertarget=eyJpdiI6IlJDVGV5UUVpMUZhOGhoQlNzTTFQdUE9PSIsInZhbHVlIjoiOHZMd2Mwdmh1SWNUbzBMalF1Y1dmd293UDBhMjNINmphT0ltcmx4RzRDRT0iLCJtYWMiOiJhNmY2MDFkZWI0YmExMGEyYjNmNjUyODQyN2Q4YjU0ZjYyMGU2ZmQ4NmRkMDgyMTIwNzBjMTExZDgyMjFiNDBlIiwidGFnIjoiIn0%3Dwayfindertarget=eyJpdiI6IlJDVGV5UUVpMUZhOGhoQlNzTTFQdUE9PSIsInZhbHVlIjoiOHZMd2Mwdmh1SWNUbzBMalF1Y1dmd293UDBhMjNINmphT0ltcmx4RzRDRT0iLCJtYWMiOiJhNmY2MDFkZWI0YmEx" ] "accept-encoding" => array:1 [ 0 => "gzip, deflate, br, zstd" ] "sec-fetch-dest" => array:1 [ 0 => "document" ] "sec-fetch-user" => array:1 [ 0 => "?1" ] "sec-fetch-mode" => array:1 [ 0 => "navigate" ] "sec-fetch-site" => array:1 [ 0 => "none" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "sec-ch-ua-platform" => array:1 [ 0 => ""Windows"" ] "sec-ch-ua-mobile" => array:1 [ 0 => "?0" ] "sec-ch-ua" => array:1 [ 0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129"" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] ]
        request_cookies
        0 of 0
        array:1 [ "wayfindertarget" => null ]
        response_headers
        0 of 0
        array:5 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Sun, 23 Feb 2025 21:16:32 GMT" ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6Imc0QVpJTVdEbGxway83dE5MZTdQK2c9PSIsInZhbHVlIjoibEI1OWJyUksva20zZklHS0Nneko1dFZpK2E2THprTm91QVdHQXpLRCt3YWRaWFFvRnRrUjNQVE9xNUV1RlVPY0d2MGVac0ZuOG9BMGFGanNYQTFhRldzRU1tMkFUUHRBMG5sZXpHa1d5TE5YSlB2aVA1Sm1QYWtxdnlKZFlWVTUiLCJtYWMiOiI1MjU4ZWIwNzY2OWQ3MTQxNzNiN2YwMTFiYWUwMTE1ZDRiMTZkYmE4MzYxMTBjZGVjOGUxN2NlNTQ0YTc0MjZlIiwidGFnIjoiIn0%3D; expires=Wed, 26 Feb 2025 09:16:32 GMT; Max-Age=216000; path=/; secure; samesite=laxXSRF-TOKEN=eyJpdiI6Imc0QVpJTVdEbGxway83dE5MZTdQK2c9PSIsInZhbHVlIjoibEI1OWJyUksva20zZklHS0Nneko1dFZpK2E2THprTm91QVdHQXpLRCt3YWRaWFFvRnRrUjNQVE9xNUV1RlVPY0d2MGVac" 1 => "alphaeurekaselectnet_session=eyJpdiI6IjZQVHRKZ2l3UlRDYlNSTEZQZE1TcUE9PSIsInZhbHVlIjoiWXQ2Q0NPQWlydFZRaVdrUkxDTjFxNkxRb3ZqWWFzc1VOTWxsT2psSm9jWmN1Tk5JVmdHanBoekFMYmtzMjZtcFNlQnkydldKNFZMTEY4dW9JMmFUeDRERXMvTlZ2dFE0L2tnb3JBQ294cTJRY05YUlpXVmVvTS9ZS0VLQVphN1AiLCJtYWMiOiJjY2MxNGZkMGM3ZDE2NzFlYWY2YmJmYTBhZDE4OTA1NDdhZjUzYjJlYWM3YjAwNDAyN2M2Y2YwMWNkZTM2NTdkIiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=laxalphaeurekaselectnet_session=eyJpdiI6IjZQVHRKZ2l3UlRDYlNSTEZQZE1TcUE9PSIsInZhbHVlIjoiWXQ2Q0NPQWlydFZRaVdrUkxDTjFxNkxRb3ZqWWFzc1VOTWxsT2psSm9jWmN1Tk5JVmdHanBoekF" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6Imc0QVpJTVdEbGxway83dE5MZTdQK2c9PSIsInZhbHVlIjoibEI1OWJyUksva20zZklHS0Nneko1dFZpK2E2THprTm91QVdHQXpLRCt3YWRaWFFvRnRrUjNQVE9xNUV1RlVPY0d2MGVac0ZuOG9BMGFGanNYQTFhRldzRU1tMkFUUHRBMG5sZXpHa1d5TE5YSlB2aVA1Sm1QYWtxdnlKZFlWVTUiLCJtYWMiOiI1MjU4ZWIwNzY2OWQ3MTQxNzNiN2YwMTFiYWUwMTE1ZDRiMTZkYmE4MzYxMTBjZGVjOGUxN2NlNTQ0YTc0MjZlIiwidGFnIjoiIn0%3D; expires=Wed, 26-Feb-2025 09:16:32 GMT; path=/; secureXSRF-TOKEN=eyJpdiI6Imc0QVpJTVdEbGxway83dE5MZTdQK2c9PSIsInZhbHVlIjoibEI1OWJyUksva20zZklHS0Nneko1dFZpK2E2THprTm91QVdHQXpLRCt3YWRaWFFvRnRrUjNQVE9xNUV1RlVPY0d2MGVac" 1 => "alphaeurekaselectnet_session=eyJpdiI6IjZQVHRKZ2l3UlRDYlNSTEZQZE1TcUE9PSIsInZhbHVlIjoiWXQ2Q0NPQWlydFZRaVdrUkxDTjFxNkxRb3ZqWWFzc1VOTWxsT2psSm9jWmN1Tk5JVmdHanBoekFMYmtzMjZtcFNlQnkydldKNFZMTEY4dW9JMmFUeDRERXMvTlZ2dFE0L2tnb3JBQ294cTJRY05YUlpXVmVvTS9ZS0VLQVphN1AiLCJtYWMiOiJjY2MxNGZkMGM3ZDE2NzFlYWY2YmJmYTBhZDE4OTA1NDdhZjUzYjJlYWM3YjAwNDAyN2M2Y2YwMWNkZTM2NTdkIiwidGFnIjoiIn0%3D; path=/; secure; httponlyalphaeurekaselectnet_session=eyJpdiI6IjZQVHRKZ2l3UlRDYlNSTEZQZE1TcUE9PSIsInZhbHVlIjoiWXQ2Q0NPQWlydFZRaVdrUkxDTjFxNkxRb3ZqWWFzc1VOTWxsT2psSm9jWmN1Tk5JVmdHanBoekF" ] ]
        session_attributes
        0 of 0
        array:5 [ "_token" => "vsjGpG4ceaVU6o2Ug9Rb7qHBhVc7ir5Xmkf7P6Su" "uc_cart_id" => "abb4c2f41c78be3cf7bf186319db5bc7" "_previous" => array:1 [ "url" => "https://alpha.eurekaselect.com/article/119179" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]
        ClearShow all
        Date ↕MethodURLData
        #12025-02-23 21:16:32GET/article/119179614361